Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in unrecognised early pregnancy
- 2 June 2016
- journal article
- case report
- Published by Springer Nature in Investigational New Drugs
- Vol. 34 (5) , 650-653
Abstract
The use of intravitreal vascular endothelial growth factor (VEGF) inhibitor medications has widened considerably to include indications affecting females of reproductive age. Our patient was inadvertently exposed to bevacizumab within the first trimester when placental growth and fetal organogenesis take place and patient suffered pregnancy loss. There is insufficient information to suggest that such use is safe, nor is there definitive evidence to suggest that it causes harm. We advise that ophthalmologists discuss pregnancy with women of childbearing age undergoing intraocular anti-VEGF injections and in pregnant woman counselling is needed to explain the potential risks and benefits.Keywords
This publication has 15 references indexed in Scilit:
- Intravitreal bevacizumab injection in unrecognised early pregnancyEye, 2014
- Serum Concentration of Vascular Endothelial Growth Factor after Bilateral Intravitreal Injection of BevacizumabKorean Journal of Ophthalmology, 2014
- Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literatureEye, 2013
- Embryo‐Fetal Transfer of Bevacizumab (Avastin) in the Rat Over the Course of Gestation and the Impact of Neonatal Fc Receptor (FcRn) BindingBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2012
- Intravitreal Bevacizumab for a Subfoveal Myopic Choroidal Neovascularization in the First Trimester of PregnancyJournal of Ocular Pharmacology and Therapeutics, 2012
- INTRAVITREAL BEVACIZUMAB DURING PREGNANCYRetina, 2010
- Early loss of pregnancy after intravitreal bevacizumab injectionActa Ophthalmologica, 2010
- Safety Implications of Vascular Endothelial Growth Factor Blockade for Subjects Receiving Intravitreal Anti–Vascular Endothelial Growth Factor TherapiesAmerican Journal of Ophthalmology, 2009
- Exposure to verteporfin and bevacizumab therapy for choroidal neovascularization secondary to punctate inner choroidopathy during pregnancyEye, 2008
- Vascular endothelial growth factor in fellow eyes of eyes injected with intravitreal bevacizumabGraefe's Archive for Clinical and Experimental Ophthalmology, 2008